Wealthfront Advisers’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-202,283
Closed -$7.29M 1022
2025
Q2
$7.29M Buy
202,283
+7,507
+4% +$249K 0.02% 288
2025
Q1
$6.06M Buy
194,776
+5,841
+3% +$185K 0.02% 310
2024
Q4
$4.82M Buy
188,935
+178,173
+1,656% +$4.72M 0.01% 338
2024
Q3
$304K Buy
+10,762
New +$298K ﹤0.01% 832
2024
Q2
Sell
-33,821
Closed -$1.03M 892
2024
Q1
$1.03M Sell
33,821
-33,185
-50% -$978K ﹤0.01% 610
2023
Q4
$1.88M Sell
67,006
-8,831
-12% -$243K 0.01% 476
2023
Q3
$2.06M Buy
75,837
+30,489
+67% +$906K 0.01% 417
2023
Q2
$1.39M Sell
45,348
-7,363
-14% -$249K 0.01% 492
2023
Q1
$1.9M Buy
52,711
+10,082
+24% +$374K 0.01% 422
2022
Q4
$1.68M Buy
42,629
+32,875
+337% +$1.37M 0.01% 440
2022
Q3
$392K Buy
9,754
+2,580
+36% +$110K ﹤0.01% 651
2022
Q2
$302K Buy
+7,174
New +$294K ﹤0.01% 684

Other funds holding RPRX